Literature DB >> 9762024

Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6.

M Tohyama1, Y Yahata, M Yasukawa, R Inagi, Y Urano, K Yamanishi, K Hashimoto.   

Abstract

BACKGROUND: A severe adverse reaction to sulfasalazine therapy has been associated with hypersensitivity syndrome, the clinical features of which are similar to infectious mononucleosis. No serologic evidence of viral infections has been reported with this syndrome; however, human herpesvirus 6 infection has not been specifically investigated, which could cause an infectious mononucleosislike syndrome. OBSERVATIONS: We report 2 cases of hypersensitivity syndrome induced by the use of sulfasalazine. The clinical features of the syndrome appeared 18 and 32 days after administration of sulfasalazine. Clinical signs included a maculopapular rash progressing to exfoliate erythroderma, fever, and lymphadenopathy. Leukocytosis, atypical lymphocytes, liver dysfunction, and renal disturbance were also observed. In 1 patient, human herpesvirus 6 variant B was isolated from peripheral blood mononuclear cells, and in both patients anti-human herpesvirus 6 IgG titers increased considerably.
CONCLUSIONS: Two cases of hypersensitivity syndrome due to sulfasalazine use were associated with the reactivation of human herpesvirus 6, which may be a required cause of hypersensitivity syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762024     DOI: 10.1001/archderm.134.9.1113

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  26 in total

1.  Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; C Burkhart; A E Cribb; W J Pichler; B K Park
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  ATL-like marked atypical lymphocytosis associated with drug-induced hypersensitivity syndrome and human herpesvirus-6 reactivation.

Authors:  Tomonori Nakazato; Kazuhito Suzuki; Ai Mihara; Yukinari Sanada; Yoshinobu Aisa; Tsunayuki Kakimoto
Journal:  Int J Hematol       Date:  2009-11-25       Impact factor: 2.490

Review 3.  Skin manifestations of drug allergy.

Authors:  Michael R Ardern-Jones; Peter S Friedmann
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 4.  Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; B K Park
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

5.  Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal neutralizing antibodies contribute to sequential infection with these viruses in childhood.

Authors:  Mariko Yoshida; Sadayoshi Torigoe; Kumiko Ikeue; Masao Yamada
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  Drug-induced hypersensitivity syndrome associated with reactivation of human herpesvirus 6 presenting with severe hepatic injury.

Authors:  Hideaki Miura; Masayuki Nakano; Naoki Yoshimura; Shigehiro Kitamura; Haruki Yamada; Masakazu Takazoe
Journal:  Clin J Gastroenterol       Date:  2008-09-03

7.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 8.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

9.  Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus.

Authors:  Atsushi Komatsuda; Yohsuke Okamoto; Takashi Hatakeyama; Hideki Wakui; Ken-ichi Sawada
Journal:  Clin Rheumatol       Date:  2007-10-19       Impact factor: 2.980

10.  Copy numbers of telomeric repeat sequences of human herpesvirus 6B in clinical isolates: possibility of mixed infections.

Authors:  Yuri Kato; Masaru Ihira; Mami Umeda; Yuki Higashimoto; Yoshiki Kawamura; Masahiro Ohashi; Junichi Ishi; Tetsushi Yoshikawa
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.